Financial News, Latest News
Immuron Limited (NASDAQ: IMRN) Revenue Grew 179% While Working to Improve Immune-Related Diseases Immuron Limited (NASDAQ: IMRN), an Australian biopharmaceutical firm, specializes in oral immunotherapeutics designed to manage immune-related diseases. Despite a sharp...
Latest News, Market Opinion
A Closer Look at VCI Global’s Revenue Growth and Business Model VCI Global (NASDAQ: VCIG) is a multi-disciplinary business and consulting firm, specializing in sectors such as listing solutions, strategic consultancy, fintech, AI, robotics, and cybersecurity. Since...
Financial News, Latest News
AES Corp (NYSE: AES) Announces Strategic Partnership with CDPQ to Support AES Ohio's Robust Growth Plans The AES Corporation (NYSE: AES) today announced that it reached an agreement to sell a 30% indirect equity interest in AES Ohio to CDPQ, a global investment group,...
